Ionis Pharmaceuticals’ (IONS) Buy Rating Reiterated at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research report released on Tuesday morning,Benzinga reports. HC Wainwright currently has a $50.00 target price on the stock. Other analysts have also recently issued research reports about the stock. Royal Bank of Canada restated an “outperform” rating and […]
HC Wainwright reiterated their buy rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research report released on Tuesday morning,Benzinga reports. HC Wainwright currently has a $50.00 target price on the stock. Other analysts have also recently issued research reports about the stock. Royal Bank of Canada restated an “outperform” rating and […]
